Pharma Mar, S.A. (BME:PHM)
Spain
· Delayed Price · Currency is EUR 98.65
+1.80 (1.86%)
Apr 28, 2026, 5:35 PM CET
Pharma Mar Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,713 | 1,289 | 1,389 | 738 | 1,158 | 1,033 | Upgrade
|
| Market Cap Growth | 29.07% | -7.20% | 88.09% | -36.23% | 12.13% | -21.36% | Upgrade
|
| Enterprise Value | 1,595 | 1,193 | 1,298 | 608 | 1,014 | 866 | Upgrade
|
| Last Close Price | 98.65 | 74.90 | 79.02 | 39.98 | 61.69 | 54.28 | Upgrade
|
| PE Ratio | 22.94 | 17.19 | 53.17 | 649.51 | 23.46 | 11.12 | Upgrade
|
| Forward PE | 37.49 | 24.03 | 36.29 | 67.76 | 16.74 | 12.76 | Upgrade
|
| PS Ratio | 7.74 | 5.82 | 7.94 | 4.67 | 5.90 | 4.49 | Upgrade
|
| PB Ratio | 6.80 | 5.12 | 6.67 | 3.82 | 5.19 | 5.81 | Upgrade
|
| P/TBV Ratio | 6.84 | 5.15 | 6.70 | 3.84 | 5.22 | 5.84 | Upgrade
|
| P/FCF Ratio | 36.70 | 27.62 | - | - | 39.30 | 57.78 | Upgrade
|
| P/OCF Ratio | 32.23 | 24.26 | 230.47 | - | 30.22 | 40.22 | Upgrade
|
| EV/Sales Ratio | 7.20 | 5.39 | 7.42 | 3.84 | 5.17 | 3.77 | Upgrade
|
| EV/EBITDA Ratio | 23.32 | 17.94 | 128.91 | - | 22.60 | 9.12 | Upgrade
|
| EV/EBIT Ratio | 26.27 | 19.64 | 200.70 | - | 24.11 | 9.37 | Upgrade
|
| EV/FCF Ratio | 34.17 | 25.56 | - | - | 34.42 | 48.46 | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.20 | 0.25 | 0.23 | 0.19 | 0.28 | Upgrade
|
| Debt / EBITDA Ratio | 0.72 | 0.72 | 4.19 | 48.68 | 0.91 | 0.51 | Upgrade
|
| Debt / FCF Ratio | 1.06 | 1.06 | - | - | 1.45 | 2.76 | Upgrade
|
| Net Debt / Equity Ratio | -0.47 | -0.47 | -0.50 | -0.61 | -0.63 | -0.86 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.77 | -1.77 | -10.27 | 103.75 | -3.11 | -1.61 | Upgrade
|
| Net Debt / FCF Ratio | -2.52 | -2.52 | 11.51 | 4.21 | -4.74 | -8.53 | Upgrade
|
| Asset Turnover | 0.60 | 0.60 | 0.51 | 0.43 | 0.52 | 0.66 | Upgrade
|
| Inventory Turnover | 0.24 | 0.24 | 0.18 | 0.29 | 0.71 | 1.46 | Upgrade
|
| Quick Ratio | 2.20 | 2.20 | 2.29 | 1.98 | 2.18 | 2.93 | Upgrade
|
| Current Ratio | 3.02 | 3.02 | 3.03 | 2.63 | 2.83 | 3.42 | Upgrade
|
| Return on Equity (ROE) | 32.59% | 32.59% | 13.00% | 0.55% | 24.62% | 66.18% | Upgrade
|
| Return on Assets (ROA) | 10.19% | 10.19% | 1.17% | -0.65% | 6.91% | 16.54% | Upgrade
|
| Return on Invested Capital (ROIC) | 51.63% | 50.82% | 7.21% | -4.85% | 77.52% | - | Upgrade
|
| Return on Capital Employed (ROCE) | 20.20% | 20.20% | 2.40% | -1.60% | 14.20% | 32.80% | Upgrade
|
| Earnings Yield | 4.38% | 5.82% | 1.88% | 0.15% | 4.26% | 8.99% | Upgrade
|
| FCF Yield | 2.73% | 3.62% | -0.65% | -3.83% | 2.54% | 1.73% | Upgrade
|
| Dividend Yield | 0.83% | - | 1.01% | 1.63% | 1.05% | 1.20% | Upgrade
|
| Payout Ratio | 18.60% | 18.60% | 43.71% | 1028.06% | 23.83% | 11.71% | Upgrade
|
| Buyback Yield / Dilution | 0.62% | 0.62% | 1.98% | 0.81% | 0.12% | 1.31% | Upgrade
|
| Total Shareholder Return | 1.45% | 0.62% | 2.99% | 2.44% | 1.18% | 2.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.